Most interestingly, the target prediction for the novel miRNA candidate located on chromosome 6 and in an intron of GLP1R (Glucagon-Like Peptide 1 Receptor) (Fig. 5A; Supplementary Fig. S5) revealed 15 target genes (Supplementary Table S2), which are enriched for several cardiac-related significantly enriched GO terms (e.g., cardiovascular system development) and pathways (e.g., cardiac hypertrophic response, hypertrophic and dilated cardiomyopathy, miRNAs in cardiomyocyte hypertrophy). The gene discussed is GLP1R; the disease is dilated cardiomyopathy.